Genetically modified (GMO) mosquitoes were released in Djibouti, East Africa to fight malaria.
What is Malaria?
Malaria is a life-threatening disease spread to humans by some types of mosquitoes. It is mostly found in tropical countries.
Transmission: It is caused by plasmodium protozoa. The plasmodium parasites spread through the bites of infected female Anopheles mosquitoes. Blood transfusion and contaminated needles may also transmit malaria.
Types of parasites: 5 Plasmodium parasite species cause malaria in humans and 2 of these species – P. falciparum and P. vivax – pose the greatest threat. The other malaria species that can infect humans are P. malariae, P. ovale, and P. knowlesi.
falciparum is the deadliest malaria parasite and the most prevalent on the African continent. P. vivax is the dominant malaria parasite in most countries outside of sub-Saharan Africa.
Symptoms: Fever and flu-like illness, including chills, headache, muscle aches, and fatigue.
Disease burden
According to the World Malaria Report, there were 247 million cases of malaria in 2021 and the estimated number of malaria deaths stood at 619 000.
According to the World Health Organization, Africa bears the brunt of the global malaria burden, accounting for 96% of malaria deaths worldwide in 2021.
Four African countries accounted for just over half of all malaria deaths worldwide: Nigeria (31.3%), the Democratic Republic of the Congo (12.6%), the United Republic of Tanzania (4.1%), and Niger (3.9%).
How do GM mosquitoes help to fight malaria?
The method targets female mosquitoes, which are predominantly responsible for malaria transmission.
It involves releasing genetically engineered male mosquitoes carrying a special gene into the wild, which then mate with females.
The introduced gene prevents female offspring from surviving to adulthood, effectively reducing the population of malaria-transmitting mosquitoes.
Male mosquitoes do not bite and therefore cannot transmit malaria.
Initiatives to control Malaria by WHO
The WHO’s Global Technical Strategy for Malaria 2016–2030 aims to reduce malaria case incidence and mortality rates by at least 40% by 2020, at least 75% by 2025, and at least 90% by 2030 against a 2015 baseline.
‘E-2025 Initiative’: The WHO has identified 25 countries with the potential to eradicate malaria by 2025 under the initiative.
High Burden to High Impact (HBHI) initiative: WHO has initiated the initiative in 11 high malaria burden countries, including India.
Indian Government Initiatives to Control Malaria:
The Government of India set a target to eliminate malaria in India by 2027.
In India, a National Framework for Malaria Elimination (NFME) has been developed and launched in 2016 aligned with the Global Technical Strategy (GTS) for malaria elimination 2016-2030.
Malaria Elimination Research Alliance-India (MERA-India): It was established by the Indian Council of Medical Research (ICMR) as a conglomeration of partners working on malaria control.